Arakelian M

Experimental Therapeutics & Pathophysiology Branch, Division of Intramural Research Program, National Institute of Mental Health, Bethesda, MD, USA.

4 papers · ORCID

ArticleKetamine

Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.

Jones GH, Gilbert JR, Johnston JN +20

Europe PMC2026
ArticlePsychedelics

Psychiatric Residents' Perspectives on Psychedelics and Psychedelic Assisted Therapy.

Barnett BS, Arakelian M, Weleff J +4

Europe PMC2025
ArticlePsilocybin

The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies.

Weleff J, Pulido-Saavedra A, Aghaei AM +8

Europe PMC2025
ArticlePsilocybin

American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up Survey.

Barnett BS, Arakelian M, Beebe D +5

Europe PMC2024